A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

The purpose of this study is to compare the intraocular pressure (IOP)-lowering efficacy and safety of two combination products in patients with open-angle glaucoma or ocular hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 or older.
Diagnosis of glaucoma or ocular hypertension.
Other protocol-defined inclusion criteria may apply.

Exclusion criteria

Under 18.
Other protocol-defined exclusion criteria may apply.

Treatment and study plan

Travoprost 40 mcg/ml + Timolol 5 mg/ml eye drops, solution (DuoTrav)

Drug

One drop in the study eye(s) once daily, 9 PM, for 6 weeks

Other names: DuoTrav

Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (Cosopt)

Drug

One drop in the study eye(s) twice daily for 6 weeks

Other names: Cosopt

Timolol Vehicle

Other

One drop in the study eye(s) once daily for 6 weeks

Primary outcomes

Mean Intra-Ocular Pressure (IOP)

Time frame: 6 weeks

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Important dates

Study start: 2006
Primary completion: 2007
Study completion: 2007
First posted: Jun 2, 2006
Registry last updated: Nov 18, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed